Lupin Limited Appoints Anand Kripalu as Independent Director Through Postal Ballot

1 min read     Updated on 13 Feb 2026, 08:17 PM
scanx
Reviewed by
Suketu GScanX News Team
Overview

Lupin Limited successfully appointed Mr. Anand Kripalu as Independent Director through postal ballot on February 13, 2026, with 96.53% approval from 90.17% shareholder participation. The special resolution received unanimous promoter support and strong backing from institutional investors, demonstrating confidence in the board appointment.

32539672

*this image is generated using AI for illustrative purposes only.

Lupin Limited has successfully appointed Mr. Anand Kripalu as an Independent Director following the completion of its postal ballot process on February 13, 2026. The pharmaceutical company announced that the special resolution for his appointment received requisite majority approval from shareholders.

Postal Ballot Results Overview

The postal ballot process demonstrated strong shareholder participation and support for the appointment. The voting results showed comprehensive engagement across all shareholder categories.

Parameter: Details
Total Shares Outstanding: 456,798,806
Total Votes Polled: 411,905,910
Participation Rate: 90.17%
Votes in Favor: 397,634,636
Votes Against: 14,271,274
Approval Rate: 96.53%

Category-wise Voting Pattern

The voting pattern revealed unanimous support from promoters and strong backing from institutional investors. Promoter and Promoter Group shareholders, holding 214,212,684 shares, voted with 100.00% participation and complete support for the resolution.

Category: Shares Held Votes Polled Participation (%) In Favor (%) Against (%)
Promoter Group: 214,212,684 214,212,684 100.00 100.00 0.00
Public Institutions: 215,348,255 196,956,088 91.46 92.76 7.24
Public Non-Institutions: 27,237,867 737,138 2.71 99.59 0.41

Public Institutions showed significant participation at 91.46% with 92.76% voting in favor, while Public Non-Institutions had lower participation at 2.71% but demonstrated strong support with 99.59% favorable votes.

Process and Timeline

The postal ballot process was conducted entirely through remote e-voting, following regulatory guidelines and MCA circulars. The company appointed National Securities Depository Limited (NSDL) as the e-voting service provider.

Key Timeline:

  • Postal Ballot Notice Date: January 06, 2026
  • Cut-off Date: January 09, 2026
  • E-voting Period: January 15, 2026 (9:00 AM) to February 13, 2026 (5:00 PM)
  • Total Shareholders on Record: 293,698

Scrutinizer Appointment and Validation

Saurabh Agarwal (Membership No. F9290) from Makarand M. Joshi & Co., Practicing Company Secretaries, served as the appointed Scrutinizer for the postal ballot process. The scrutinizer confirmed that no invalid votes were recorded and all procedural requirements under the Companies Act, 2013 were fulfilled.

The resolution was classified as a Special Resolution requiring higher approval thresholds, which was comfortably achieved with the overwhelming shareholder support. The appointment strengthens Lupin's board composition with independent directorship expertise.

Historical Stock Returns for Lupin

1 Day5 Days1 Month6 Months1 Year5 Years
-0.53%-0.87%+0.50%+13.14%+8.60%+108.86%

Lupin Allots 75,273 Equity Shares Under Employee Stock Option Plan

1 min read     Updated on 13 Feb 2026, 05:14 PM
scanx
Reviewed by
Shriram SScanX News Team
Overview

Lupin Limited allotted 75,273 equity shares under its ESOP on February 13, 2026, following approval by the Operations and Finance Committee. The shares, with a face value of ₹2 each, were granted to employees upon exercising vested options. Post-allotment, the company's paid-up capital stands at ₹91,40,86,438 comprising 45,70,43,219 equity shares, demonstrating the company's commitment to employee equity participation.

32528667

*this image is generated using AI for illustrative purposes only.

Lupin Limited has announced the allotment of 75,273 equity shares under its Employee Stock Option Plan (ESOP) on February 13, 2026. The pharmaceutical company informed stock exchanges about this development through a regulatory filing pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Share Allotment Details

The Operations and Finance Committee of Lupin approved the allotment during its meeting held on February 13, 2026. The allotted shares represent fully paid-up equity shares with a face value of ₹2 each.

Parameter: Details
Shares Allotted: 75,273 equity shares
Face Value: ₹2 per share
Allotment Date: February 13, 2026
Beneficiaries: Employees of company and subsidiaries

Impact on Share Capital

Following the ESOP allotment, Lupin's capital structure has been updated to reflect the increased share count. The allotment was made upon exercising of vested options granted to employees under the company's stock option plans.

Capital Structure: Post-Allotment
Issued and Paid-up Capital: ₹91,40,86,438
Total Equity Shares: 45,70,43,219 shares
Face Value per Share: ₹2

Regulatory Compliance

The company has duly informed both the National Stock Exchange of India Limited and BSE Limited about the share allotment. The disclosure was signed by Amit Kumar Gupta, Company Secretary and Compliance Officer, ensuring compliance with regulatory requirements for listed companies.

This ESOP allotment reflects Lupin's ongoing commitment to employee participation in the company's growth through equity-based compensation schemes for its workforce and subsidiary employees.

Historical Stock Returns for Lupin

1 Day5 Days1 Month6 Months1 Year5 Years
-0.53%-0.87%+0.50%+13.14%+8.60%+108.86%

More News on Lupin

1 Year Returns:+8.60%